SEP-227162
Encyclopedia
SEP-227,162 is an antidepressant
being developed by Sepracor
which is currently in clinical trials. It acts as a serotonin-norepinephrine reuptake inhibitor
. As of 1st July 2009, the compound has not shown sufficient efficacy, and its future development is unknown.
Antidepressant
An antidepressant is a psychiatric medication used to alleviate mood disorders, such as major depression and dysthymia and anxiety disorders such as social anxiety disorder. According to Gelder, Mayou &*Geddes people with a depressive illness will experience a therapeutic effect to their mood;...
being developed by Sepracor
Sepracor
Sepracor, Inc. is a pharmaceutical company founded in 1984 by Tim Barberich. It was originally located in Princeton, New Jersey and then re-located to Marlborough, Massachusetts. On October 12, 2010, the company changed its name to Sunovion.-Company history:The company's initial focus was on the...
which is currently in clinical trials. It acts as a serotonin-norepinephrine reuptake inhibitor
Serotonin-norepinephrine reuptake inhibitor
Serotonin–norepinephrine reuptake inhibitors are a class of antidepressant drugs used in the treatment of major depression and other mood disorders...
. As of 1st July 2009, the compound has not shown sufficient efficacy, and its future development is unknown.